tirzepatide and epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 Can Weight Loss Injections Cause

Discussion The present study evaluated the improvement of sperm quality in semen supplemented with LC and CoQ10 and the resulting pregnancy rates in patients with ASZ

Because GLP-1s also affect brain pathways involved in mood and reward, some users notice changes in motivation or mental energy as their dose changes

Study author Patricia Rodriguez, PhD, MPH, principal applied scientist at Truveta, which partly funded the study, noted the following additional highlights of the studys findings, to MNT : Patients on tirzepatide were over two times more likely to experience 10% weight loss and three times more likely to experience 15% weight loss within a year, compared to patients on semaglutide

For this indication, it seems higher doses are more effective as some of the impacts on blood glucose max out at the lower doses

Importantly she needed one that could isolate the GLP (7-37) peptide (Barany, Barany

Do my symptoms require gallbladder imaging rather than blood tests alone